RNase-protection analyses confirmed that these transcripts were indeed BDNF mRNA, and that a similar size band was protected in RNA isolated from cultured neonatal sympathetic neurons (data not shown), indicating that at least some of the BDNF mRNA in the SCG was synthesized by neurons.
To determine whether BDNF was also made in the adult SCG, and to confirm that the biologically active protein was synthesized, we performed Western blot analysis using an anti-BDNF antibody. To demonstrate the specificity of this antibody, we performed three different controls. First, we confirmed that, of the recombinant neurotrophins, this antibody recognized only BDNF (Figure 1Bi ), and that this antibody was able to recognize as little as 0.5 ng of recombinant BDNF (data not shown). Second, we demonstrated that a BDNF-immunoreactive band of a size similar to both recombinant (data not shown) and transfected BDNF was present in the brains of BDNF ϩ/ϩ but not BDNF Ϫ/Ϫ mice ( Figure 1Bii ). Third, we demonstrated that preabsorption of the antibody with the original BDNF peptide immunogen blocked the ability of the antibody to detect brainderived BDNF on a Western blot ( Figure 1Bii ).
Having confirmed the specificity of this BDNF antibody, we next determined whether BDNF protein was synthesized by sympathetic neurons of the SCG, as it was in the mouse brain. Western blot analysis of protein derived from the adult SCG revealed the presence of a , 1994) . We therefore created a minigene comprised in lysates (10 g) from vaccinia virus-BDNF infected PC12 cells (PC12). To further ensure the specificity of the BDNF antibody, the antibody was preincubated (CON preab and KO preab) with an excess of BDNF peptide immunogen. This peptide corresponds to spinal cords of individual D498 and control postnatal day 4 litamino acids 128-147 of the carboxy terminus of the human BDNF termates were analyzed by Western blots. The levels of BDNF were sequence. Note that preincubation eliminated the BDNF-specific similar in 3 control (CON SC) and 3 D498 (D498 SC) spinal cords at band in the BDNF ϩ/ϩ brain. this age. 20 ng of recombinant human BDNF was used as a control (C) Circulating BDNF is not detectable in the DBH:BDNF mice. (i) in this experiment. To control for systemic BDNF in the circulation, sera from control (D) BDNF protein is expressed in the SCG of adult control and (CON) and transgenic D498 (D498) animals were analyzed by West-DBH:BDNF mice, as detected by Western blot analysis. Cell or tissue ern blot analysis. BDNF was not detectable in either case. (ii) To lysates were separated on polyacrylamide gels, transferred to nitrotest the reliability of the BDNF extraction from blood, 50 ng of human cellulose, and probed with an antibody specific to BDNF. (i) A BDNFrecombinant BDNF was added to the blood of a BDNF Ϫ/Ϫ mouse.
immunoreactive band similar in size to BDNF produced by vaccinia The serum was then extracted, and Western blot analysis was pervirus-infected PC12 cells (PC12) is detected in equal amounts of formed (BDNF ϩ Blood). Human recombinant BDNF was used as protein from the control adult mouse SCG (CON SCG) and in the a control (BDNF) the first prediction, we performed immunocytochemistry A total of four transgenic DBH:BDNF lines were examwith an antibody specific to the full-length form of the ined. Three of these four founder lines showed increased TrkB receptor (Allendoerfer et al., 1994) on spinal cord expression of BDNF mRNA in the SCG, as detected by sections from thoracic levels 1-4, the region containing Northern blot analysis (data not shown). BDNF mRNA preganglionic neurons that innervate the SCG. This anallevels were not increased in regions such as the cortex ysis demonstrated that preganglionic neurons located or liver, which do not contain noradrenergic or adrenerin the interomediolateral (IML) region are immunoreacgic cell populations (data not shown). On the basis of tive for the full-length TrkB receptor ( Figure 2F ). As a these results, two lines of animals, D498 and D481, both positive control, we observed specific cell body staining of which expressed increased BDNF mRNA in the SCG, in motoneurons located in the ventral horn (data not were chosen for more extensive analysis.
shown). As a negative control, we performed immunocyTo quantitate the level of overexpression of BDNF tochemistry using preimmune serum, and found no speprotein in sympathetic neurons from these two lines of cific staining in the IML or ventral horn (data not shown). mice, we first performed Western blot analysis. This
To test the second prediction, that preganglionic neuanalysis demonstrated that BDNF protein was increased rons would hypertrophy in response to sympathetic neuapproximately 4-fold and 2-fold, respectively, in the ron-derived BDNF, we measured the size of cholineadult SCG of lines D498 and D481 relative to control acetyltransferase (ChAT)-positive cell bodies in the IML mice of the same genetic background ( Figure 1D ). To between thoracic levels 1-4; ChAT is a specific marker confirm that this overexpression took place in sympafor preganglionic neurons. Image analysis on immunothetic neurons, we performed immunocytochemistry for stained sections revealed that transgenic ChAT-positive BDNF, using a BDNF antibody that is effective for immu-IML neurons had an increased cross-sectional area relanocytochemistry, as previously demonstrated (Pattive to wild-type neurons ( Figure 3A ) (wild type: 69.86 Ϯ terson et al., 1996) . This analysis revealed that levels 1.89 m 2 , D498: 78.87 Ϯ 1.87 m 2 , mean Ϯ SE, p Ͻ of BDNF protein were increased in many but not all 0.001; n ϭ 3). When these cell sizes were organized into sympathetic neurons in both lines of transgenic mice bins and expressed as a percentage of the total ChATrelative to wild-type controls (data not shown); this propositive IML cell population, there was a shift of the moter has previously been reported to target transgene entire population toward greater sizes ( Figure 3B ). Thus, expression in anywhere from 5% to 95% of sympathetic preganglionic, TrkB-positive neurons respond to inneurons (Mercer et al., 1991) .
creased sympathetic BDNF with somatic hypertrophy. To ensure that any observed effects on preganglionic innervation were not due to systemic BDNF, we measured BDNF levels in the circulation. Western blot analyIncreased Sympathetic BDNF Leads sis demonstrated that circulating BDNF was undetectto Preganglionic Hyperinnervation able in either control or line D498 animals ( Figure Ci) . of the SCG This lack of detectable BDNF in the blood was not due If sympathetic BDNF is a growth factor for preganglionic to its degradation, because when recombinant BDNF neurons, then we would predict that increased BDNF was added to the blood of BDNF Ϫ/Ϫ animals prior to would lead to increased preganglionic innervation. To analysis, it was recovered intact (Figure 1Cii) . test this prediction, we first visualized presynaptic con-A second potential source of increased BDNF for pretacts in the SCG by performing immunocytochemistry ganglionic neurons in DBH:BDNF mice was the CNS.
with an antibody to synapsin, a presynaptic marker proWestern blot analysis of various regions of the adult tein. In wild-type ganglia, there was diffuse punctate CNS revealed that BDNF levels were only increased staining ( Figure 2A ). In contrast, similar analysis of D498 in the hindbrain (data not shown), as predicted if the and D481 transgenic animals revealed an increase in transgene was expressed appropriately in noradrenerboth the density and pattern of synapsin immunostaingic neurons (Hoyle et al., 1994) . However, to directly ing; synapsin-positive terminals in the transgenic anidemonstrate that preganglionic neurons were not exmals appeared as dense clusters on and around sympaposed to increased BDNF at the time of preganglionic thetic neurons within the ganglion ( Figure 2B ). To ensure innervation of the SCG, we examined BDNF in the neothat these synaptic contacts originated from the pregannatal spinal cord. Western blot analysis confirmed that glionic neurons, we resected the cervical sympathetic levels of BDNF were similar in the spinal cord of line trunk (CST), which carries the incoming axons from the D498 versus control littermates at postnatal day 4 (Figpreganglionic neurons. Except for sparse punctate ure 1Ciii). Thus, the only sources of increased BDNF for staining due to intrinsic synaptic connections within the preganglionic neurons in DBH:BDNF mice were their ganglion, there was an almost complete disappearance sympathetic neuron targets.
of the dense, punctate synaptic staining when the CST was resected, confirming that the majority of synaptic Preganglionic Neurons Express Full-Length TrkB, contacts in the transgenic SCG originated from the preand Hypertrophy in Response to Increased ganglionic inputs ( Figure 2C ). To confirm that this inSympathetic Neuron-Derived BDNF crease in synapsin staining reflected an increased numIf sympathetic neuron-derived BDNF functions as a target-derived growth factor for preganglionic neurons, ber of synapses within the SCG, we quantitated synapse Increased sympathetic expression of BDNF leads to an increased density of preganglionic synapses in the SCG, as detected immunocytochemically using an antibody again a presynaptic terminal marker protein, synapsin.
(A-C) Synapsin was immunocytochemically localized in sections of SCG from adult control (A) and transgenic animals of line D498 (B). Note that both the density and pattern of synapsin immunostaining differs, with large clusters of synapsin-immunoreactive terminals in the transgenic ganglia (arrow). To demonstrate that the increased synapsin-positive terminals in the transgenic mice derived from preganglionic axons, the CST was transected and, two weeks later, the SCG was immunostained for synapsin (C). This led to the disappearance of the vast majority of synapsin-positive terminals, although a few presumably intrinsic synapses remained (arrow). In all three panels, sympathetic neuron cell bodies are indicated by arrowheads. (D and E) Sympathetic innervation of the pineal gland is similar in control and transgenic mice. To visualize sympathetic innervation, sections of control (D) and line D481 (E) pineal glands were immunostained with an antibody specific to tyrosine hydroxylase. Note that the density and pattern of tyrosine hydroxylase immunoreactivity was similar in both cases (arrows).
(F) Preganglionic neurons express full-length TrkB. Spinal cord sections at thoracic levels 1-4 were immunostained with an antibody specific to the full-length form of TrkB, demonstrating that preganglionic neurons in the intermediolateral column (arrow) displayed TrkB immunoreactivity. Dotted lines demarcate the gray and white matter of the spinal cord. Scale bar ϭ 200 m 2 .
density by electron microscopy ( Figures 4G and 4H ).
(neurons per 0.033 mm 2 , wild type: 28.8 Ϯ .91, D498: 21.3 Ϯ .54, p Ͻ 0.0001; n ϭ 5 for wild type, n ϭ 4 Sections from the SCG of adult control and line D498 mice were randomly sampled with a 41 m 2 grid, and for D498). When the synapse density was corrected for these differences in neuronal density, the relative synthe number of synapses within this defined area were determined. This analysis demonstrated a 1.7-fold inapse number/neuron in the DBH:BDNF mice was increased approximately 2.5-fold ( Figure 3E ), confirmcrease in synapse density in the SCG of line D498 relative to control animals (wild type: 0.85 Ϯ 0.05, line D498:
ing that increased sympathetic neuron-derived BDNF caused an increase in preganglionic synaptic innerva-1.47 Ϯ .18, p ϭ 0.014; n ϭ 3 animals each, at least 40 grids per animal). Plotting the number of synapses per tion density. grid as a distribution histogram revealed that the increased mean synapse density reflected a shift to larger Increased Sympathetic BDNF Leads to an Increase in the Size but Not the Number of Preganglionic synapse numbers in the entire population ( Figure 5E ).
To determine whether the increased synapse density Axons Innervating the SCG In the peripheral nervous system, an increase in the in DBH:BDNF animals corresponded to an increase in the number of synapses per neuron, we measured neuamount of target organ-derived neurotrophin leads to an increase in the density of innervation, as well as in ronal density on cresyl violet-stained sections. Image analysis demonstrated that the neuronal density was the number of neurons innervating that target, largely as a consequence of increased neuronal survival (Albers significantly higher in control than in line D498 mice et al., 1994) . To determine whether the increased preganglionic innervation of the SCG in the DBH:BDNF mice was accompanied by a similar increase in the number of innervating preganglionic neurons, we examined crosssections of the preganglionic nerve, the CST, from adult wild-type and transgenic D498 and D481 animals. Surprisingly, electron microscopy ( Figures 4A, 4B , 4D, and 4E) and axon profile counts showed no difference in the number of axons within the transgenic versus wild-type CST (wild type: 1259 Ϯ 57, D498: 1044 Ϯ 55, D481: 1011 Ϯ 95, p Ͼ 0.05; n ϭ 3). However, measurement of axon sizes revealed a shift toward larger sizes of both unmyelinated and myelinated axons in the transgenic versus wild-type CST ( Figures 4A, 4B , 4D, and 4E; Figures 5A-5D ). This shift in size distribution was also reflected in an increase in the diameter of CST axons in transgenic compared to wild-type mice (unmyelinated axons, wild type: 0.75 Ϯ .01 m, D498: 0.85 Ϯ 0.02 m, D481: 0.96 Ϯ 0.02 m, p Ͻ 0.0001; myelinated axons, wild type: 1.41 Ϯ 0.04 m, D498: 1.70 Ϯ 0.04 m, D481: 1.76 Ϯ 0.05 m, p Ͻ 0.001; n ϭ 3). Thus, hyperinnervation of the SCG in DBH:BDNF mice was due to an increase in the number of synaptic terminals per axon, and not to an increase in the number of preganglionic axons, and presumably neurons, innervating the SCG.
Sympathetic Neurons' Size Is Increased in DBH:BDNF Mice
A somewhat surprising phenotype observed in the DBH:BDNF transgenic mice was a hypertrophy of sympathetic neurons of the SCG ( Figure 3C ), which accounted for the decreased neuronal density in line D498. Image analysis quantitation revealed a significant increase in the cross-sectional area of SCG neurons in transgenic D498 and D481 mice relative to wild-type controls (wildtype: 371.84 Ϯ 5.70 m 2 , D498: 507.65 Ϯ 10.46 m 2 , D481: 486.94 Ϯ 9.25 m 2 , p Ͻ 0.001; n ϭ 3). One potential explanation for this phenomenon is that the TrkB receptor was aberrantly induced in response to the increase in sympathetic BDNF, thereby leading to autocrine/paracrine effects within the ganglia. However, immunostaining revealed no TrkB-like immunoreactivity in either transgenic or control SCG (data not shown). Moreover, SCG cell counts revealed no significant increase in the relative number of sympathetic neurons in transgenic versus wild-type ganglia (p Ͼ 0.05). Finally, Figures 2D and 2E ) and the iris (data not shown), both (A and B) Preganglionic neurons hypertrophy in response to inof which receive sympathetic efferents exclusively from creased sympathetic neuron-derived BDNF. To determine the size of preganglionic neurons in control versus transgenic mice, spinal cord sections from thoracic levels 1-4 were stained for ChAT, and the size of ChAT-positive neurons in the intermediolateral column was determined by image analysis. (A) represents the average pre-(E) The relative density of synapses per sympathetic neuron is inganglionic cell size, while (B) represents the size distribution of creased in response to increased neuron-derived BDNF in ChAT-positive neurons in the IML of control versus transgenic ani-DBH:BDNF mice and decreased in response to an absence of BDNF mals of line D498. Note that the small increase in average neuronal synthesis in BDNF Ϫ/Ϫ mice. To quantitate the relative synapse size is due to a shift to greater size of the entire preganglionic number per neuron within the SCG, synapses were counted in elecpopulation.
tron microscopic sections of a defined area (41 m 2 ). The synapse (C and D) Sympathetic neuron cell body size is increased in density was calculated and then corrected for neuronal density to DBH:BDNF mice. (C) The average sympathetic neuron size is signifiderive the relative synapse number/neuron (see the text). This analycantly larger in transgenic animals of both lines D481 and D498 than sis demonstrated that relative synaptic innervation per neuron was it is in control mice of the same genetic background. However, two significantly increased in line D498 transgenic mice (D498) relative weeks following removal of the CST and the corresponding loss of to adult wild-type mice of the same genetic background (WT), and preganglionic innervation, cell body sizes are similar in control and significantly decreased in two-to three-week-old BDNF Ϫ/Ϫ mice transgenic mice of both lines (D).
(Ϫ/Ϫ) relative to their control (ϩ/ϩ) littermates. the SCG, revealed no apparent difference in the density DBH:BDNF mice was responsible for the hypertrophy.
To test this hypothesis, we resected the CST, thereby and pattern of sympathetic innervation; TH-positive axons appeared as a similar network of lattice-like nerve removing the preganglionic input, and analyzed sympathetic neuron sizes two weeks later. These experiments fibers and terminals in transgenic and control pineal glands ( Figures 2D and 2E) .
revealed that, when the preganglionic innervation was removed, the difference in size of transgenic and wildSince the transgenic sympathetic neurons were similar to control neurons with regards to all of these patype sympathetic neurons was eliminated ( Figure 3D ), an effect due to both a decrease in size of the transgenic rameters, with the exception of cell body size, we hypothesized that the increased preganglionic input in neurons and an increase in size in the wild-type neurons Ernfors et al., 1994) , preganglionic synaptic innervation to the SCG would be decreased. To test this prediction, we analyzed the SCG of 2-to 3-week-old BDNF Ϫ/Ϫ mice by electron microscopy. These studies demonstrated that SCG synapse density per 41 m 2 grid was decreased approximately 1.5-fold in BDNF Ϫ/Ϫ mice relative to their wild-type littermates (wildtype ϭ 1.3 Ϯ .17; BDNF Ϫ/Ϫ ϭ 0.88 Ϯ .06, p Ͻ 0.05; n ϭ 3 animals each, at least 40 grids per animal). Plotting the number of synapses per grid as a distribution histogram revealed that this decrease reflected a shift to smaller synapse numbers for the entire population ( Figure 5F ).
To determine whether the decrease in synapse density in the BDNF Ϫ/Ϫ mice corresponded to a decrease in the relative number of synapses per neuron, we measured neuronal density. Image analysis of 2-to 3-weekold animals revealed that neuronal density was significantly higher in BDNF Ϫ/Ϫ mice than in their BDNF ϩ/ϩ littermates (neurons per 0.033 m 2 , BDNF Ϫ/Ϫ: 47.7 Ϯ .79, BDNF ϩ/ϩ: 32.5 Ϯ .76, p Ͻ 0.0001; n ϭ 3). When the synapse density was corrected for these differences, the relative synapse number/neuron in the BDNF Ϫ/Ϫ mice was approximately 2.2-fold lower than in BDNF ϩ/ϩ littermates ( Figure 3E ).
To determine whether the decreased synapse density observed in the BDNF Ϫ/Ϫ mice was due to a decreased number of synapses per axon, or to a decreased number of preganglionic axons, we analyzed the CST by electron microscopy. These studies demonstrated that both the number and size of axons in the CST were decreased in 2-to 3-week-old BDNF Ϫ/Ϫ mice ( Figures 4C and  4F) . In 2-to 3-week-old control littermates, the mean number of axons in the CST was 1666 Ϯ 121, as compared to 1034 Ϯ 95 in 2 to 3 week-old BDNF Ϫ/Ϫ mice, a 1.6-fold decrease that was significantly different (p Ͻ 0.02). Moreover, CST axon size was decreased from .93 Ϯ .01 m 2 to .70 Ϯ m 2 in the absence of BDNF, a result that was highly significant (p Ͻ 0.0001; n ϭ 3). Thus, the lack of BDNF led to a decrease in both synaptic innervation density and preganglionic axon number, with the former being greater than the latter. dynamically regulating the density of their preganglionic of preganglionic synapses per axon. Since the sympathetic neuron number is not decreased in the BDNF Ϫ/Ϫ innervation (Purves and Lichtman, 1980) . In experiments mice, this decreased innervation likely reflects a direct presented here, we demonstrate that sympathetic neueffect on preganglionic neurons. Such a deficit is remiron-derived BDNF is one growth factor that is likely to niscent of the central nervous system of the NGF Ϫ/Ϫ fulfill this role. In particular, our studies support this mice, where the basal forebrain cholinergic neurons surconclusion with the following findings. First, they demvive the loss of NGF, but the cholinergic innervation onstrate that both developing and mature sympathetic density in the hippocampus is decreased. Together, neurons express BDNF protein, and that the preganglithese data indicate that one of the major functions of onic neurons that innervate them express the full-length neuron-derived neurotrophins may well be to dynamiTrkB/BDNF receptor. Second, they demonstrate that cally regulate the level of synaptic innervation. when levels of sympathetic neuron-derived BDNF inData presented here also provide support for the idea crease, there is a coincident increase in the density of that the level of preganglionic innervation regulates sympreganglionic synapses in the SCG, but no increase pathetic neuron morphology. The somatic hypertrophy in the number of innervating axons and, presumably, observed in the DBH:BDNF mice was not accompanied neurons. Third, these studies demonstrate that when by either increased numbers of sympathetic neurons BDNF expression is lost in the BDNF Ϫ/Ϫ mice, there and/or increased sympathetic target organ innervation. is a decrease in preganglionic axons innervating the Moreover, removal of the preganglionic input to the SCG SCG, and an even larger decrease in the density eliminated the size difference observed between control of synaptic innervation per neuron. Together, these and transgenic sympathetic neurons. On the basis of studies support the conclusion that sympathetic neuthese observations, we propose that hyperinnervation ron-derived BDNF selectively regulates the level of preof sympathetic neurons leads to the observed increase ganglionic synaptic input.
Discussion
in sympathetic soma size; such an increase may well Although there is some precedent for these findings be necessary to accommodate the increased number with regards to neuron-target organ interactions, there of preganglionic synapses, and is likely accompanied by are also some major differences. The similarities are increased dendritic complexity (Voyvodic, 1989) . What largely twofold. First, for neuron-target organ interacis the mechanism whereby the level of preganglionic tions, the level of target innervation is modulated by innervation could determine sympathetic neuron morvariations in target-derived growth factors; at the prephology? Two likely possibilities involve an activityganglionic-sympathetic synapse, variations in sympadependent mechanism and/or a preganglionic anterothetic BDNF similarly modulated the level of pregangligrade trophic factor. Precedent for the latter derives onic innervation. Second, increased terminally derived from studies involving the neuromuscular junction, NGF (Miller et al., 1994) or increased target territory where evidence indicates that an anterograde myo- (Voyvodic, 1989) retrogradely signal to mediate hypertrophic factor, possibly a neuregulin (Florini et al., 1996 ; trophy of peripheral neuron cell bodies; a similar retroFalls et al., 1993), regulates muscle morphology and grade preganglionic hypertrophy was observed here function. In fact, osteogenic protein-1 selectively causes with increased sympathetic BDNF. However, there is sympathetic neuron dendritic growth and is a candidate one major difference between the role of BDNF at this for such an anterograde factor (Lein et al., 1995) ; whether neuronal synapse and NGF in the periphery. Competipreganglionic neurons synthesize this growth factor has tion for limiting amounts of NGF at the time of target not yet been determined. innervation retrogradely determine the amount of symTogether, these findings indicate that BDNF is a sympathetic neuron cell death; increased exogenous NGF pathetic neuron-derived growth factor that dynamically leads to the developmental rescue of these neurons regulates preganglionic innervation density. One predicand a corresponding increase in the number of neurons tion of this finding, based on earlier work at this synapse innervating the same amount of target territory (re-(reviewed in Purves et al., 1988) is that variations in the viewed in Levi-Montalcini, 1987) . In contrast, even amount of peripheral NGF might regulate sympathetic though the DBH promoter is induced at E10.5 (Kapur et neuron synthesis of BDNF, as has been shown for senal., 1991), well before the postnatal period of axonal sory neurons (Apfel et al., 1996) . If such an upregulation pruning in the CST (Aguayo et al., 1973) , there is no occurs in sympathetic neurons, then this would provide increase in the number of axons in the CST of either the basis for a trophic factor cascade that could modify line of transgenic mice. Instead, there is hypertrophy neuronal circuitry over more than one synapse (Purves of preganglionic axons and a selective increase in the and Lichtman, 1980). For example, increases in sympanumber of synapses per axon. Thus, sympathetic BDNF thetic target territory and NGF during normal growth regulates the density of preganglionic innervation but would cause increased neuronal production of BDNF not, apparently, the number of innervating neurons.
and a consequent increase in preganglionic innervation. This conclusion is supported by the data from the Moreover, this cascade would provide a mechanism for BDNF Ϫ/Ϫ mice. Whereas the lack of target-derived dynamic alterations in preganglionic innervation as a NGF leads to the loss of sympathetic and most sensory function of the amount of NGF available to any given neurons in the NGF Ϫ/Ϫ mice (Crowley et al., 1994) , neuron. In fact, dynamic remodelling of sympathetic our CST axon counts indicate that many preganglionic neuron dendrites, and presumably synaptic input, has neurons survive the loss of sympathetic-derived BDNF.
been observed in adult animals (Purves et al., 1986) . Instead, there is a decrease in preganglionic innervation
We propose that principles elucidated at this well to the SCG, which is due to both a decrease in preganglicharacterized synapse generalize to many neuronal synapses in the CNS. It is now well documented that BDNF onic axon number and a decrease in the relative number sucrose solutions and sectioned on the cryostat prior to immunocycan regulate both acute synaptic effects and neuronal tochemical or morphometric analyses. morphology within the CNS (reviewed in Thoenen, 1995;  For resection experiments, animals were anaesthetized with so- Lo, 1995) . Moreover, neuronal synthesis of BDNF is regdium pentobarbital (35 mg/kg), and the cervical sympathetic trunk ulated as a function of neural activity (Zafra et al., 1990;  (CST), which carries the preganglionic axons to the SCG, was unilat- Patterson et al., 1992; Nawa et al., 1995) . We propose, erally transected approximately 1-2 mm from the base of the SCG. To prevent regeneration, a piece of the nerve was removed. For on the basis of data presented here, that activity-depenelectron microscopy (EM), animals were anaesthetized as described dent variations in neuronal BDNF synthesis could lead above. The SCG were removed with approximately 3 mm of the to long-term alterations in synaptic input. Such a model CST attached, immersion-fixed in 1.6% glutaraldehyde in 0.1M PB would provide a mechanism whereby levels and pat-(pH 7.3), and processed for EM as described below.
terns of neuronal activity sufficient to increase neuronal BDNF synthesis, such as LTP (Patterson et al., 1992) ,
RNA Isolation and Analysis

could lead to permanent alterations in synaptic input
Total and poly Aϩ RNA were isolated from cultured L cells and sympathetic ganglia, and 32P-labeled BDNF antisense RNA probes density on a per-neuron level. Moreover, a trophic factor were used to probe Northern blots as previously described (Acheson cascade such as that observed for the target organet al., 1991). RNase-protection assays were performed using the sympathetic neuron-preganglionic neuron circuit could same BDNF riboprobe as previously described (Chibbar et al., 1993) .
well serve to propagate such changes over several central synapses.
Western Blot Analysis
Ganglia, brains, and spinal cord tissue were lysed in Tris-buffered saline (TBS) lysis buffer containing 137 mM NaCl, 20 mM Tris (pH Experimental Procedures 8.0), 1% (v/v) NP-40, 10% v/v glycerol, 1 mM phenylmethylsulfonylfluoride (PMSF), 10 g/ml aprotinin, 0.2 g/ml leupeptin, and 0.1% Construction of the DBH:BDNF Transgenic Mice SDS. Samples were rocked for 20 min at 4ЊC and centrifuged for The 1.6 kb DBH promoter (Hoyle et al., 1994) was isolated by digest-15 min at 15,000 rpm. The supernatant was normalized for protein ing a 9.0 kb Eco RI fragment of the human DBH gene (Mercer et concentration using a BSA protein assay reagent (Pierce, Rockford, al., 1991; gift of E. Mercer and R. Palmiter) with Sph I and Sty I. IL). Supernatants were boiled in sample buffer (2% SDS, 100 mM The 1.6 kb DBH fragment was subsequently isolated, purified, and dithiothreitol, 10% glycerol, 0.05% bromophenol blue) for 5 min, subcloned into the Hinc II and Sph I sites in pGEM4Z (Promega).
followed by SDS-PAGE. For analysis of blood samples, 1 ml of blood The BDNF open reading frame (Leibrock et al., 1989) was isolated was added to the same protease inhibitors plus heparin, centrifuged by RT-PCR from rat brain mRNA, sequenced, and cloned into the for 5 min, and the serum removed. 0.5% trifluoroacetic acid (TFA) Bam HI and Hind III sites of pBluescript (Stratagene). A 1.0 kb Bam in H 2O was added to 0.5 ml of serum, and, after centrifugation, 0.5 HI fragment that contained an SV40 intron and polyadenylation sigml of the supernatant was purified by Sep-Pak C18, concentrated nal was subcloned into the Bam HI site downstream of the BDNF by speed vacuum, and analyzed by SDS-PAGE. As a control for the open reading frame. The 1.6 kb DBH promoter was then isolated specificity of the BDNF antibody, recombinant BDNF and/or lysates from pGEM4Z (Promega) by Hpa II digestion and subcloned into from PC12 cells infected with a vaccinia virus expressing the human the Cla I site upstream of the BDNF open reading frame. The resul-BDNF open reading frame were used (the latter the kind gift of Drs. tant 3.4 kb minigene was sequenced and isolated free of vector Sangeeta Pareek and Richard Murphy, MNI). After electrophoresis, sequences by digestion of the plasmid with BssHII. Transgenic mice proteins were transferred to 0.2 m nitrocellulose for 1 hr at 0.5 were generated from the DBH:BDNF transgene by the Canadian Amps. Membranes were washed 3 ϫ 10 min in dH2O followed by NeuroSciences Network transgenic core facility (McGill University).
2 ϫ 10 min in PBS. Following the washes, membranes were blocked in 5% nonfat dry milk in PBST (PBS ϩ 0.1% Tween) for 2 hr at room Genotyping of Transgenic Animals temperature, then incubated with an antibody directed against a DBH:BDNF mice were genotyped using Southern blot analysis and/ peptide specific to BDNF (Santa Cruz; 1:5000) overnight at 4ЊC. For or PCR on tail DNA extracts. For Southern blot analysis, genomic preabsorption studies, 5 g of the BDNF peptide immunogen (Santa DNA was digested with Sal I, separated on 1% agarose gels, transCruz) was added to 0.2 g BDNF antibody and incubated at 4ЊC ferred to nitrocellulose, and probed with a 32P-labeled riboprobe overnight. Membranes were subsequently washed 3 ϫ 10 min in directed against sequences in the 1.6 kb human DBH promoter, PBST, incubated with a goat anti-rabbit horseradish peroxidaseusing standard techniques. Mice heterozygous for a targeted mutaconjugated secondary antibody (1:10,000; Boehringer Mannheim) tion in the BDNF gene (Ernfors et al., 1994) were obtained from for 1 hr at room temperature, then washed 3 ϫ 10 min in PBST. Jackson Labs (Bar Harbor). Progeny from BDNF heterozygote Following manufacturer's protocols, proteins were detected using crosses were screened for the mutant allele(s) using PCR.
enhanced chemiluminescence (Amersham) and XAR film (Kodak). Blots were quantitated using NIH Image Software.
Animals and Surgical Procedures
For biochemical analysis, animals were sacrificed with sodium penImmunocytochemistry The following primary antibodies were used for immunocytochemistobarbital, and tissues were immediately removed and processed for Northern blots, RNase-protection assays, and Western blots.
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